SEC Form 4 · accession 0001209191-18-021583
TRANSENTERIX INC. · TRXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Ph D Hsiao
Director
Period of report
Mar 22, 2018
Accepted (ET)
Mar 26, 2018 · 8:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2018 | X | 400,000 | $1.65 | A | 3,562,536 | D | |
| Common StockF2 | holding | — | — | — | 1,257,694 | I | Hsu Gamma Investments, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $1.65 | Mar 22, 2018 | X | 400,000 | D | Mar 22, 2013 | Mar 22, 2018 | Common Stock | 400,000 | 0 | D |
Explanation of responses
- F1On March 22, 2018, the reporting person exercised warrants to purchase 400,000 shares of common stock of TransEnterix, Inc., par value $0.001 per share, for a purchase price of $1.65 per share.
- F2Dr. Hsiao is the general partner of Hsu Gamma Investments, L.P.